{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:19:10Z","timestamp":1783480750072,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071984"],"award-info":[{"award-number":["82071984"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071894"],"award-info":[{"award-number":["82071894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91959117"],"award-info":[{"award-number":["91959117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019092","name":"Science Fund for Distinguished Young Scholars of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6687"],"award-info":[{"award-number":["2024JJ6687"]}],"id":[{"id":"10.13039\/501100019092","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Changsha","award":["KP2403036"],"award-info":[{"award-number":["KP2403036"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-03928-8","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:56:10Z","timestamp":1745715370000},"page":"3877-3885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunotherapy may promote the occurrence of radiation-induced brain injury in NSCLC patients with brain metastases undergoing radiotherapy: a retrospective propensity score-matching and inverse probability of treatment weighting study"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-5449","authenticated-orcid":false,"given":"Sai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JingYi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"3928_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27:1345\u201356.","journal-title":"Nat Med"},{"key":"3928_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584\u201394.","journal-title":"Mayo Clin Proc"},{"key":"3928_CR3","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295:2483\u201391.","journal-title":"JAMA"},{"key":"3928_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/neuonc\/noab101","volume":"23","author":"N Lamba","year":"2021","unstructured":"Lamba N, Wen PY, Aizer AA. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021;23:1447\u201356.","journal-title":"Neuro Oncol"},{"key":"3928_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/jitc-2023-006871","volume":"11","author":"M Altan","year":"2023","unstructured":"Altan M, Wang Y, Song J, Welsh J, Tang C, Guha-Thakurta N, et al. Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I\/II trial. J Immunother Cancer. 2023;11:8.","journal-title":"J Immunother Cancer"},{"key":"3928_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol. 2011;29:134\u201341.","journal-title":"J Clin Oncol"},{"key":"3928_CR7","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1126\/scitranslmed.abm6543","volume":"15","author":"J Cheng","year":"2023","unstructured":"Cheng J, Jiang J, He B, Lin WJ, Li Y, Duan J, et al. A phase 2 study of thalidomide for the treatment of radiation-induced blood-brain barrier injury. Sci Transl Med. 2023;15:6543.","journal-title":"Sci Transl Med."},{"key":"3928_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/jnci\/djy150","volume":"111","author":"TM Wang","year":"2019","unstructured":"Wang TM, Shen GP, Chen MY, Zhang JB, Sun Y, He J, et al. Genome-wide association study of susceptibility loci for radiation-induced brain injury. J Natl Cancer Inst. 2019;111:620\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"3928_CR9","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1470-2045(17)30380-7","volume":"18","author":"N Shaverdian","year":"2017","unstructured":"Shaverdian N, Lisberg AE, Bornazyan K, Veruttipong D, Goldman JW, Formenti SC, et al. Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial. Lancet Oncol. 2017;18:895\u2013903.","journal-title":"Lancet Oncol"},{"key":"3928_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102830","volume":"144","author":"F Petrelli","year":"2019","unstructured":"Petrelli F, De Stefani A, Trevisan F, Parati C, Inno A, Merelli B, et al. Combination of radiotherapy and immunotherapy for brain metastases: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019;144: 102830.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3928_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.radonc.2017.08.009","volume":"125","author":"Y An","year":"2017","unstructured":"An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, et al. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol. 2017;125:80\u20138.","journal-title":"Radiother Oncol"},{"key":"3928_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","volume":"100","author":"L Chen","year":"2018","unstructured":"Chen L, Douglass J, Kleinberg L, Ye X, Marciscano AE, Forde PM, et al. Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2018;100:916\u201325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3928_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3171\/2016.9.JNS161585","volume":"127","author":"O Cohen-Inbar","year":"2017","unstructured":"Cohen-Inbar O, Shih HH, Xu Z, Schlesinger D, Sheehan JP. The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. J Neurosurg. 2017;127:1007\u201314.","journal-title":"J Neurosurg"},{"key":"3928_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s12672-024-01560-6","volume":"15","author":"N Elyan","year":"2024","unstructured":"Elyan N, Schwenkenbecher P, Grote-Levi L, Becker JN, Merten R, Christiansen H, et al. Radiotherapy in patients with brain metastases with and without concomitant immunotherapy: comparison of patient outcome and neurotoxicity. Discov Oncol. 2024;15:656.","journal-title":"Discov Oncol"},{"key":"3928_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3171\/2023.4.JNS2349","volume":"139","author":"S Yomo","year":"2023","unstructured":"Yomo S, Oda K, Oguchi K. Synergistic effects of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with lung cancer and brain metastases: a propensity score-matched analysis. J Neurosurg. 2023;139:1628\u201337.","journal-title":"J Neurosurg"},{"key":"3928_CR16","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2217\/fon-2023-0207","volume":"19","author":"J Li","year":"2023","unstructured":"Li J, Li W, Xu S, Zhu H. Brain injury after cranial radiotherapy combined with immunotherapy for brain metastases in lung cancer: a retrospective study. Future Oncol. 2023;19:947\u201359.","journal-title":"Future Oncol"},{"key":"3928_CR17","doi-asserted-by":"publisher","first-page":"175883592311754","DOI":"10.1177\/17588359231175438","volume":"15","author":"RD Merkin","year":"2023","unstructured":"Merkin RD, Chiang VL, Goldberg SB. Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy? Ther Adv Med Oncol. 2023;15:17588359231175438.","journal-title":"Ther Adv Med Oncol"},{"key":"3928_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cancers16193388","volume":"16","author":"T Ranjan","year":"2024","unstructured":"Ranjan T, Podder V, Margolin K, Velcheti V, Maharaj A, Ahluwalia MS. Immune checkpoint inhibitors in the management of brain metastases from non-small cell lung cancer: a comprehensive review of current trials, guidelines and future directions. Cancers (Basel). 2024;16:9.","journal-title":"Cancers (Basel)."},{"key":"3928_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13014-022-02096-1","volume":"17","author":"XY Xie","year":"2022","unstructured":"Xie XY, Peng HH, Zhang X, Pan YL, Zhang Z, Cao PG. Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases. Radiat Oncol. 2022;17:132.","journal-title":"Radiat Oncol"},{"key":"3928_CR20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S1470-2045(22)00213-3","volume":"23","author":"JKW Gerritsen","year":"2022","unstructured":"Gerritsen JKW, Zwarthoed RH, Kilgallon JL, Nawabi NL, Jessurun CAC, Versyck G, et al. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study. Lancet Oncol. 2022;23:802\u201317.","journal-title":"Lancet Oncol"},{"key":"3928_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.radonc.2019.04.015","volume":"137","author":"X Zhuo","year":"2019","unstructured":"Zhuo X, Huang X, Yan M, Li H, Li Y, Rong X, et al. Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. 2019;137:16\u201323.","journal-title":"Radiother Oncol"},{"key":"3928_CR22","unstructured":"Diagnoses and treatments of radiation-induced brain injury: an expert consensus. Chin J Neuromed 2019;18:541\u2013549."},{"key":"3928_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/neuonc\/nos307","volume":"15","author":"N Verma","year":"2013","unstructured":"Verma N, Cowperthwaite MC, Burnett MG, Markey MK. Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol. 2013;15:515\u201334.","journal-title":"Neuro Oncol"},{"key":"3928_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11912-019-0818-y","volume":"21","author":"FS Ali","year":"2019","unstructured":"Ali FS, Arevalo O, Zorofchian S, Patrizz A, Riascos R, Tandon N, et al. Cerebral radiation necrosis: incidence, pathogenesis, diagnostic challenges, and future opportunities. Curr Oncol Rep. 2019;21:66.","journal-title":"Curr Oncol Rep"},{"key":"3928_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"3928_CR26","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18:e143\u201352.","journal-title":"Lancet Oncol"},{"key":"3928_CR27","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF McCaffrey","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32:3388\u2013414.","journal-title":"Stat Med"},{"key":"3928_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268\u201374.","journal-title":"Ann Intern Med"},{"key":"3928_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12964-024-01591-0","volume":"22","author":"T Qin","year":"2024","unstructured":"Qin T, Guo L, Wang X, Zhou G, Liu L, Zhang Z, et al. Repetitive transcranial magnetic stimulation ameliorates cognitive deficits in mice with radiation-induced brain injury by attenuating microglial pyroptosis and promoting neurogenesis via BDNF pathway. Cell Commun Signal. 2024;22:216.","journal-title":"Cell Commun Signal"},{"key":"3928_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3389\/fonc.2019.00567","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Yi X, Gao J, Li L, Liu L, Qiu T, et al. Chemotherapy potentially facilitates the occurrence of radiation encephalopathy in patients with nasopharyngeal carcinoma following radiotherapy: a multiparametric magnetic resonance imaging study. Front Oncol. 2019;9:567.","journal-title":"Front Oncol"},{"key":"3928_CR31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3389\/fimmu.2017.00517","volume":"8","author":"K Lumniczky","year":"2017","unstructured":"Lumniczky K, Szatmari T, Safrany G. Ionizing radiation-induced immune and inflammatory reactions in the brain. Front Immunol. 2017;8:517.","journal-title":"Front Immunol"},{"key":"3928_CR32","first-page":"212","volume":"6","author":"NM D'Souza","year":"2016","unstructured":"D\u2019Souza NM, Fang P, Logan J, Yang J, Jiang W, Li J. Combining radiation therapy with immune checkpoint blockade for central nervous system malignancies. Front Oncol. 2016;6:212.","journal-title":"Front Oncol"},{"key":"3928_CR33","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1007\/s00330-020-07514-0","volume":"31","author":"PH Kim","year":"2021","unstructured":"Kim PH, Suh CH, Kim HS, Kim KW, Kim DY, Aizer AA, et al. Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis. Eur Radiol. 2021;31:4114\u201329.","journal-title":"Eur Radiol"},{"key":"3928_CR34","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamaoncol.2015.1206","volume":"1","author":"S Goyal","year":"2015","unstructured":"Goyal S, Silk AW, Tian S, Mehnert J, Danish S, Ranjan S, et al. Clinical management of multiple melanoma brain metastases: a systematic review. Jama Oncol. 2015;1:668\u201376.","journal-title":"Jama Oncol"},{"key":"3928_CR35","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","volume":"4","author":"AM Martin","year":"2018","unstructured":"Martin AM, Cagney DN, Catalano PJ, Alexander BM, Redig AJ, Schoenfeld JD, et al. Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation. Jama Oncol. 2018;4:1123\u20134.","journal-title":"Jama Oncol"},{"key":"3928_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3171\/2019.4.JNS19822","volume":"133","author":"MJ Shepard","year":"2020","unstructured":"Shepard MJ, Xu Z, Donahue J, Eluvathingal Muttikkal TJ, Cordeiro D, Hansen L, et al. Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study. J Neurosurg. 2020;133:685\u201392.","journal-title":"J Neurosurg"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-03928-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:47:57Z","timestamp":1758721677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-03928-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3928"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-03928-8","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This retrospective study was carried out in accordance with the Declaration of Helsinki, had approval from the Medical Ethics Review Committee of Xiangya Hospital Central South University (Ethics approval number: 2024111490).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}